Skyrizi 150 MG/ML penml
Ended Awarded
- Contract number
- SPE2DB25FQ74M
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $26,538
Award facts
- Contract value 100% obligated
- $26,538.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of SKYRIZI 150 mg/mL pen injectors, with a ceiling value of $26,538.00 under a firm fixed-price contract awarded on September 15, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract was awarded on a competitive basis with no set-aside designation, and performance will be completed at AmerisourceBergen's Conshohocken, Pennsylvania facility by September 16, 2025.
SKYRIZI is a biologic medication used in the treatment of plaque psoriasis and other inflammatory skin conditions, representing a specialized pharmaceutical product within the broader scope of the DLA Medical Supply Chain's pharmaceutical support mission. AmerisourceBergen Drug Corp, as a major pharmaceutical distributor headquartered in Pennsylvania, maintains extensive federal contracts supplying brand-name and generic medications, biologics, and medical supplies to support military and veteran healthcare systems. This delivery order exemplifies the company's role as a critical vendor for federal medical procurement, fulfilling specific pharmaceutical needs through the comprehensive vehicle established to support Defense Health Agency and other government healthcare stakeholders.
Quick answers
Who was awarded contract SPE2DB25FQ74M?
SPE2DB25FQ74M was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 15, 2025.
How much is contract SPE2DB25FQ74M worth?
The government has obligated $26,538 on SPE2DB25FQ74M.
Is contract SPE2DB25FQ74M an order under another contract?
Yes. SPE2DB25FQ74M is a delivery order under SPE2DB22D3004, an indefinite delivery contract.
Was contract SPE2DB25FQ74M competed?
The extent of competition for SPE2DB25FQ74M was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award